A Study to Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy
Clinical trial NCT04058704 · UNKNOWN
Trial details
- NCT number
- NCT04058704
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-20
- Primary completion
- 2022-12-31
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.